Lupus resistance is associated with marginal zone abnormalities in an NZM murine model

Laboratory Investigation

Volumn 87, Issue 1, 2007, Pages 14-28

  Duan, Biyan ^a   Croker, Byron P ^a,b   Morel, Laurence ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

B cells; Lupus; Marginal zone; Mouse

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL MIGRATION; CELL STRUCTURE; CONGENIC STRAIN; CONTROLLED STUDY; FEMALE; GENE; GENE LOCUS; GENE SILENCING; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MOUSE; MOUSE STRAIN; NEW ZEALAND BLACK MOUSE; NONHUMAN; PERITONEUM CELL; PHENOTYPE; PRIORITY JOURNAL; SLE1 GENE; SLE2 GENE; SLE3 GENE; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; IMMUNOGLOBULIN G; KIDNEY CORTEX; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, INBRED NZB; MICE, INBRED STRAINS; MICROSATELLITE REPEATS; SPLEEN;

EID: 33845805695     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700497     Document Type: Article

References (44)

1. Rudofsky UH, Evans BD, Balaban SL, et al. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab Invest 1993;68:419-426.
2. Morel L, Rudofsky UH, Longmate JA, et al. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994;1:219-229.
3. Morel L, Mohan C, Yu Y, et al. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J Immunol 1997;158:6019-6028.
4. Waters ST, Fu SM, Gaskin F, et al. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin Immunol 2001;100:372-383.
5. Waters ST, McDuffie M, Bagavant H, et al. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med 2004;199:255-264.
6. Morel L, Croker BP, Blenman KR, et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci USA 2000;97:6670-6675.
7. Morel L, Tian X-H, Croker BP, et al. Epistatic modifers of autoimmunity in a murine model of lupus nephritis. Immunity 1999;11:131-139.
8. Wakeland EK, Liu K, Graham RR, et al. Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001;15:397-408.
9. Martin F, Kearney JF. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1B cells as part of a 'natural immune memory'. Immunol Rev 2000;175:70-79.
10. Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CD5. Ann Rev Immunol 2002;20:253-300.
11. Mohan C, Morel L, Yang P, et al. Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthr Rheumat 1998;41:1652-1662.
12. Xu Z, Duan B, Croker BP, et al. Genetic dissection of the murine lupus susceptibility locus Sle2: contributions to increased peritoneal B-1a cells and lupus nephritis map to different loci. J Immunol 2005;175:936-943.
13. Wither JE, Roy V, Brennan LA. Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F-1 mice. Clin Immunol 2000;94:51-63.
14. Grimaldi CM, Michael DJ, Diamond B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 2001;167:1886-1890.
15. Li YJ, Li H, Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med 2002;195:181-188.
16. Wither JE, Loh C, Lajoie G, et al. Colocalization of expansion of the splenic marginal zone population with abnormal B cell activation and autoantibody production in B6 mice with an introgressed New Zealand black chromosome 13 interval. J Immunol 2005;175:4309-4319.
17. Sen G, Bikah G, Venkataraman C, et al. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1B cells. Eur J Immunol 1999;29:3319-3328.
18. Martin F, Kearney JF. Marginal-zone B cells. Nat Rev 2002;2:323-335.
19. Morel L, Yu Y, Blenman KR, et al. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mammal Genome 1996;7:335-339.
20. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15:241-250.
21. Xu Z, Duan B, Croker BP, et al. STAT4 deficiency reduces autoantibody production and glomerulonephritis in a mouse model of lupus. Clin Immunol 2006;120:189-198.
22. Boackle SA, Holers VM, Chen XJ, et al. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 2001;15:775-785.
23. Sobel ES, Mohan C, Morel L, et al. Adoptive transfer of NZM-derived lupus susceptibility locus SLE1 on murine chromosome 1 by bone marrow. Arthr Rheumat 1997;40:1072.
24. Morel L, Mohan C, Yu Y, et al. Multiplex inheritance of component phenotypes in a murine model of lupus. Mammal Genome 1999;10:176-181.
25. Braverman IM. Study of autoimmune disease in New Zealand mice. I. genetic features and natural history of NZB, NZY and NZW strains and NZB-NZW hybrids. J Invest Dermatol 1968;50:483-499.
26. Kelley VE, Winkelstein A. Age- and sex-related glomerulonephritis in New Zealand white mice. Clin Immunol Immunopathol 1980;16:142-150.
27. Chen Y, Cuda C, Morel L. Genetic determination of T cell help in loss of tolerance to nuclear antigens. J Immunol 2005;174:7692-7702.
28. Won WJ, Kearney JF. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J Immunol 2002;168:5605-5611.
29. Cyster JG. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Ann Rev Immunol 2005;23:127-159.
30. Karlsson MCI, Guinamard R, Bolland S, et al. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J Exp Med 2003;198:333-340.
31. Nolte MA, Arens R, Kraus M, et al. B cells are crucial for both development and maintenance of the splenic marginal zone. J Immunol 2004;172:3620-3627.
32. Srivastava B, Quinn III WJ, Hazard K, et al. Characterization of marginal zone B cell precursors. J Exp Med 2005;202:1225-1234.
33. Groeneveld PHP, Erich T, Kraal G. In vivo effects of LPS on lymphocyte-B subpopulations - migration of marginal zone-lymphocytes and IgD-blast formation in the mouse spleen. Immunobiol 1985;170:402-411.
34. Fernandes G, Yunis EJ, Good RA. Age and genetic influence on immunity in NZB and autoimmune-resistant mice. Clin Immunol Immunopathol 1976;6:318-333.
35. Encinas JA, Wicker LS, Peterson LB, et al. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2. Nat Genet 1999;21:158-160.
36. Tarakhovsky A, Kanner SB, Hombach J, et al. A role for Cd5 in TCR-mediated signal-transduction and thymocyte selection. Science 1995;269:535-537.
37. Wardemann H, Yurasov S, Schaefer A, et al. Predominant autoantibody production by early human B cell precursors. Science 2003;301:1374-1377.
38. Srivastava B, Lindsley RC, Nikbakht N, et al. Models for peripheral B cell development and homeostasis. Semin Immunol 2005;17:175-182.
39. Chung JB, Wells AD, Adler S, et al. Incomplete activation of CD4Tcells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness. J Immunol 2003;171:1758-1767.
40. Mohan C, Yu Y, Morel L, et al. Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J Immunol 1999;162:6492-6502.
41. Attanavanich K, Kearney JF. Marginal zone, but not follicular B cells, are potent activators of naive CD4T cells. J Immunol 2004;172:803-811.
42. Mandik-Nayak L, Racz J, Sleckman BP, et al. Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell help. J Exp Med 2006;203:1985-1998.
43. Hippen KL, Tze LE, Behrens TW. CD5 maintains tolerance in anergic B cells. J Exp Med 2000;191:883-889.
44. Cariappa A, Shoham T, Liu HY, et al. The CD9 tetraspanin is not required for the development of peripheral B cells or for humoral immunity. J Immunol 2005;175:2925-2930.